Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • SEC, FDA sign info-sharing agreement as a ‘signal to the market’ on insider trading

SEC, FDA sign info-sharing agreement as a ‘signal to the market’ on insider trading

September 2, 2026Posted inBiotechnology

The SEC and the FDA have signed a three-year agreement to step up cooperation and information-sharing capabilities aiming to improve each organization’s regulatory and enforcement missions.

Post navigation

Previous Post
TScan axes 75% of workforce to make room for solid tumor programs
Next Post
Teva autoimmune antibody notches ph. 2 win in celiac disease

Recent Posts

  • Four Tiny Snail Species New to Science Found on Limestone Karsts of Laos
  • Stable chromosomes, shifting centromeres: how East African killifish rewrite karyotype evolution
  • AI model combining ultrasound and digital breast tomosynthesis improves specificity in breast cancer triage
  • Wireless Power Study Reveals the Sweet Spot for Charging Many Devices at Once
  • From Waste Wood to Radar Stealth: Biomass Carbon Aerogels Emerge as Ultralight Microwave Absorbers

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top